Last reviewed · How we verify

NCT07064434

Sacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension

Recruiting now NA Last updated 14 July 2025
What this trial tests

NA trial testing Sacral canal block combined with general anesthesia in Postoperative Pain in 80 participants. Currently enrolling.

Timeline
1 November 2024
Primary endpoint
30 October 2025
30 October 2025

Quick facts

Lead sponsorGeneral Hospital of Ningxia Medical University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment80
Start date1 November 2024
Primary completion30 October 2025
Estimated completion30 October 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

General Hospital of Ningxia Medical University

Who can join

45 and older, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To observe the efficacy and safety of sacral canal block in controlled blood pressure reduction during hip replacement in the elderly, and to provide a better option for controlled blood pressure reduction during clinical hip surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other General Hospital of Ningxia Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07064434.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing